Related Experiment Video

Updated: Jun 3, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Association of Helicobacter pylori infection with cardiovascular disease--is it just a myth?

Dimitrios K Christodoulou1, Haralampos J Milionis, Panagiota Pappa

  • 1Department of Internal Medicine, Medical School of Ioannina, University of Ioannina, Greece.

European Journal of Internal Medicine
|March 16, 2011
PubMed

Insights

This study found no link between Helicobacter pylori infection and cardiovascular disease (CVD) in patients undergoing endoscopy. Eradicating H. pylori is not recommended for preventing CVD.

Area of Science:

  • Gastroenterology
  • Cardiology
  • Infectious Disease

Background:

  • Helicobacter pylori (H. pylori) infection is common globally.
  • Potential links between H. pylori and cardiovascular disease (CVD) remain debated.
  • Understanding this association is crucial for public health and clinical practice.

Purpose of the Study:

  • To investigate the association between H. pylori infection and documented cardiovascular disease (CVD).
  • To test the hypothesis that H. pylori positivity increases CVD risk in patients undergoing upper gastrointestinal endoscopy.

Main Methods:

  • A cohort of 202 patients undergoing elective upper gastrointestinal endoscopy was studied.
  • H. pylori infection was confirmed using rapid urease testing and histological examination.
  • Cardiovascular disease (CVD) was assessed via the Rose questionnaire.
  • Multivariate logistic regression analysis was employed to control for confounding factors.

Main Results:

  • Over half the subjects (51.5%) tested positive for H. pylori infection.
  • Forty patients (19.8%) had a documented history of CVD.
  • Logistic regression confirmed associations between CVD and known atherosclerotic risk factors, but not with H. pylori infection.

Conclusions:

  • The study found no statistically significant association between H. pylori infection and cardiovascular disease.
  • Current evidence does not support H. pylori eradication as a strategy for CVD prevention.
  • Further research may be needed to fully elucidate any indirect roles of H. pylori in cardiovascular health.
Abstract

More Related Videos

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology03:33

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology

Published on: May 23, 2025

Related Concept Videos

Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...